Larry Liriano-Espinal
Endocrinology, Diabetes & Metabolism · Crystal River, FLNPI 1932514833
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 180 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 12.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,726, more than ten times the $111 reported in 2019. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in FL, where the typical reported total is $3,445.
Across 180 payments — averaging $23.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corcept Therapeutics$507
- Xeris Pharmaceuticals, Inc.$354
- Dexcom, Inc.$317
- Novo Nordisk$306
- Sanofi-aventis U.S. LLC$294
- Johnson & Johnson$269
- plus $2K from 25 others
What the payments were for
- Food & beverage$4,156100%
- Education$110%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corcept Therapeutics | 25 | $507 |
| Xeris Pharmaceuticals, Inc. | 17 | $354 |
| Dexcom, Inc. | 11 | $317 |
| Novo Nordisk | 16 | $306 |
| Sanofi-aventis U.S. LLC | 11 | $294 |
| Johnson & Johnson | 10 | $269 |
| Novartis | 11 | $253 |
| Insulet Corporation | 7 | $227 |
| Kyowa Kirin, Inc. | 6 | $213 |
| Lilly USA, LLC | 15 | $201 |
| Tandem Diabetes Care, Inc. | 3 | $139 |
| Recordati_rare_diseases_inc. | 7 | $139 |
| Impel Pharmaceuticals Inc. | 1 | $95 |
| Amphastar Pharmaceuticals, Inc. | 4 | $94 |
| Ascendis Pharma Endocrinology Inc | 5 | $91 |
| AstraZeneca | 3 | $78 |
| Bayer | 3 | $68 |
| Ionis Pharmaceuticals, Inc. | 3 | $67 |
| Mannkind Corporation | 2 | $63 |
| Radius Health, Inc. | 3 | $56 |
| GSK | 2 | $54 |
| E.r. Squibb & Sons, L.L.C. | 3 | $53 |
| AbbVie | 2 | $38 |
| Pfizer | 2 | $34 |
| BETA Bionics, Inc. | 2 | $31 |
| Madrigal Pharmaceuticals | 1 | $29 |
| Boehringer Ingelheim | 1 | $24 |
| Halozyme Inc | 1 | $20 |
| Sequel Med Tech, LLC | 1 | $19 |
| IBSA Pharma Inc. | 1 | $19 |
| Embecta Corp. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DEXCOM G7 GSS (161)$125
- CRYSVITA$115
- Omnipod$115
- XARELTO$111
How this compares
$4,167 in reported general payments places this provider in the 50th percentile of 586 endocrinology, diabetes & metabolism providers in Florida.
See all endocrinology, diabetes & metabolism providers in Florida →
Other endocrinology, diabetes & metabolism in Crystal River
- Jay SkylerMiami$2.2M
- Arelis MaderaPort Charlotte$1.7M
- Damon TantonOrlando$1.2M
- Gaston PonteMelbourne$906K
- Brian LakeLargo$888K
- David SuttonJacksonville$783K
- Mae Sheikh AliJacksonville$751K
- Richard PratleyOrlando$735K
- Lee MetchickDeland$728K
- Misha DenhamCoral Gables$673K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.